Promising lung cancer treatment approved for Cancer Drugs Fund

NICE

28 March 2019 - A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, thanks to a new NICE recommendation.

NICE has today published draft final guidance recommending durvalumab (Imfinzi, AstraZeneca).

It will be made available on the NHS in England immediately for people with locally advanced unresectable non-small-cell lung cancer, who have already had platinum-based chemoradiation.

Read NICE recommendation

Michael Wonder

Posted by:

Michael Wonder